Evidence map›Paper›PMID 29695781›Full record

ArticleScientific reports2018

The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein.

Tsitsi D Mubaiwa, Lauren E Hartley-Tassell, Evgeny A Semchenko, Christopher J Day, Michael P Jennings, Kate L Seib

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Characterisation and Immunogenicity ofFrontiers in immunology · 2024
    Article
  3. Article
  4. TheScience signaling · 2021
    Article
  5. Article
  6. TheVaccines · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tsitsi D MubaiwaInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Lauren E Hartley-TassellInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Evgeny A SemchenkoInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Christopher J DayInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Michael P JenningsInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Kate L SeibInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia. k.seib@griffith.edu.au.
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis is a Gram-negative bacterial pathogen that causes life threatening meningitis and septicemia. Neisseria Heparin Binding Antigen (NHBA) is an outer membrane protein that binds heparin and heparan sulfate and DNA. This protein is one of the four antigens in the meningococcal serogroup B vaccine Bexsero. In the current study, we sought to define the full glycan-binding repertoire of NHBA to better understand its role in meningococcal pathogenesis and vaccine efficacy. Glycan array analysis revealed binding to 28 structures by recombinant NHBA. Surface plasmon resonance was used to confirm the binding phenotype and to determine the affinity of the interactions. These studies revealed that the highest affinity binding of NHBA was with chondroitin sulfate (K

Indexed as

Antibodies, BacterialAntigens, BacterialCarrier ProteinsChondroitin SulfatesHumansMeningococcal VaccinesNeisseriaNeisseria meningitidisSerogroup4CMenB vaccineAntibodies, BacterialAntigens, BacterialCarrier Proteinschondroitin sulfate DChondroitin SulfatesMeningococcal Vaccines

Identifiers

PMID29695781
PMCPMC5916922
OpenAlexW2805539559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.